China-based Nanjing Baifu Laser Technology Co., Ltd reportedly raised close to RMB 100 million (USD 14.9 million) in a Series A financing round led by Yuanbio Venture Capital, with existing investor Northern Light Venture Capital also participating. The proceeds will be used for clinical filings and global market promotion of its home-grown high-end medical and aesthetic optoelectronic equipment, including picosecond lasers, erbium lasers, alexandrite lasers, dye lasers, and others.
Company Focus and Market Presence
Baifu Laser is focused on the research and development, manufacturing, sales, and scientific research services of products in the dermatology, plastic surgery, rehabilitation medicine, and general health fields. The company’s business presence mainly covers Spanish-speaking and Middle Eastern markets, where it aims to expand its footprint with the new funding.
Funding Round Details
The Series A round, led by Yuanbio Venture Capital, highlights the potential of Baifu Laser’s optoelectronic equipment in the global market. The participation of Northern Light Venture Capital, an existing investor, indicates continued confidence in the company’s growth prospects. The funds will support Baifu Laser’s efforts to bring its innovative products to a wider international audience.-Fineline Info & Tech
